Table 1. Demographic and clinical characteristics of the study sample according to coronary arteriography.
Variable | Total (n=186) | The results of coronary arteriongraphy | P Value | |
---|---|---|---|---|
Non-CAD (n=63) (Stenosis <50%) | CAD (n=123) (Stenosis ≥50%) | |||
Age, y | 67.4±11.6 | 62.7±10.7 | 69.7±11.3 | 0.000 |
Gender (male), % | 56.5 (105/186) | 44.4 (28/63) | 62.6 (77/123) | 0.018 |
Smokers, % | 28.5 (53/186) | 19.0 (12/63) | 33.3 (41/123) | 0.410 |
Alcohol consumers,% | 15.6 (29/186) | 17.5 (11/63) | 14.6 (18/123) | 0.615 |
Diabetes mellitus, % | 27.4 (51/186) | 15.9 (10/63) | 33.3 (41/123) | 0.015 |
Hypertension, % | 62.9 (117/186) | 47.6 (30/63) | 70.7 (87/123) | 0.002 |
NYHA class III or IV, % | 33.3 (62/186) | 28.6 (18/63) | 35.8 (44/123) | 0.324 |
Lipid drugs medication, % | 83.3 (149/186) | 71.4 (45/63) | 89.4 (110/123) | 0.002 |
Blood glucose, mmol/L | 5.51±1.71 | 5.28±1.48 | 5.62±1.82 | 0.065 |
Serum creatinine, umol/L | 93.0±25.4 | 82.0±18.3 | 98.6±26.8 | 0.000 |
Blood urea nitrogen, mmol/L | 6.02±2.25 | 5.69±2.21 | 6.19±2.25 | 0.121 |
cardiac troponin I, ng/L | 1.60±8.50 | 0.17±0.83 | 2.35±10.43 | 0.000 |
Myoglobin, μg/L | 90.4±369 | 25.6±13.6 | 123.6±450.7 | 0.000 |
CK-MB, IU/L | 28.5±61.7 | 16.1±6.0 | 34.9±75.0 | 0.282 |
Total cholesterol, mmol/L | 4.23±1.06 | 4.50±0.99 | 4.08±1.07 | 0.008 |
LDL cholesterol, mmol/L | 2.64±0.89 | 2.82±0.77 | 2.54±0.94 | 0.019 |
HDL cholesterol, mmol/L | 1.09±0.3 | 1.14±0.27 | 1.06±0.32 | 0.023 |
Serum triglycerides, mmol/L | 1.61±1.03 | 1.69±1.27 | 1.56±0.88 | 0.903 |
Apolipoprotein A1, g/L | 1.08±0.16 | 1.11±0.16 | 1.06±0.20 | 0.033 |
Apolipoprotein B, g/L | 0.86±0.22 | 0.87±0.22 | 0.85±0.23 | 0.400 |
Apolipoprotein A1/B | 1.38±0.40 | 1.39±0.36 | 1.37±0.42 | 0.599 |
Paraoxonase1 activity, U/L | 351±123 | 380±133 | 336±115 | 0.026 |
Values are expressed as mean ± standard deviation or percentage